{"format":1,"id":"118-hr-1734","congress":118,"number":"H.R. 1734","kind":"bill","group":"bills","title":"Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023","title_source":"Short Titles as Enacted","official_title":"To require coordinated National Institute of Standards and Technology science and research activities regarding illicit drugs containing xylazine, novel synthetic opioids, and other substances of concern, and for other purposes.","titles":[{"type":"Official Title as Introduced","title":"To require coordinated National Institute of Standards and Technology science and research activities regarding illicit drugs containing xylazine, novel synthetic opioids, and other substances of concern, and for other purposes."},{"type":"Short Title(s) from Engrossed Amendment Senate bill text","title":"Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023"},{"type":"Short Title(s) from Engrossed Amendment Senate bill text","title":"TRANQ Research Act of 2023"},{"type":"Short Titles from ENR (Enrolled) bill text","title":"Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023"},{"type":"Short Titles from ENR (Enrolled) bill text","title":"TRANQ Research Act of 2023"},{"type":"Short Title(s) as Introduced","title":"TRANQ Research Act"},{"type":"Short Title(s) as Introduced","title":"Testing, Rapid Analysis, and Narcotic Quality Research Act"},{"type":"Short Title(s) as Reported to House","title":"Testing, Rapid Analysis, and Narcotic Quality Research Act"},{"type":"Short Title(s) as Reported to House","title":"TRANQ Research Act"},{"type":"Short Title(s) as Passed House","title":"TRANQ Research Act"},{"type":"Short Title(s) as Passed House","title":"Testing, Rapid Analysis, and Narcotic Quality Research Act"},{"type":"Display Title","title":"TRANQ Research Act of 2023"},{"type":"Short Titles as Enacted","title":"Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023"},{"type":"Short Titles as Enacted","title":"TRANQ Research Act of 2023"},{"type":"Short Titles as Passed Senate","title":"Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023"},{"type":"Short Titles as Passed Senate","title":"TRANQ Research Act of 2023"}],"outcome":"became_law","law_number":"Public Law 118-23","introduced":"2023-03-23","chambers":{"house":{"status":"voice","date":"2023-12-04","vote":null,"how":"voice_vote","words":"Resolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote. (text: CR H6087-6088)"},"senate":{"status":"voice","date":"2023-06-22","vote":null,"how":"unanimous_consent","words":"Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text of amendment in the nature of a substitute: CR S2250-2251)"}},"president":{"status":"signed","date":"2023-12-19"},"vice_president_tie_breaker":null,"latest_action":{"text":"Became Public Law No: 118-23.","date":"2023-12-19"},"nominees":null,"amendments":[],"other_votes":[{"chamber":"house","date":"2023-05-11","question":"On Motion to Suspend the Rules and Pass, as Amended","title":"TRANQ Research Act","result":"Passed","yea":425,"nay":0,"present":0,"not_voting":10,"kind":"final_candidate","source":"https://clerk.house.gov/evs/2023/roll212.xml"}],"crs_summary":{"date":"2023-12-19","stage":"Public Law","blocks":[{"k":"h","t":"Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023 or the TRANQ Research Act of 2023"},{"k":"p","t":"This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other new psychoactive substances."},{"k":"p","t":"In particular, NIST must support"},{"k":"li","t":"basic measurement science and research;","d":1},{"k":"li","t":"near-real time spectrometry capabilities (i.e., a technique for rapidly identifying the chemical composition of a substance);","d":1},{"k":"li","t":"strategies and voluntary best practices for handling, transporting, and analyzing such substances; and","d":1},{"k":"li","t":"collaboration with other government agencies, institutions of higher education, and the private sector to enhance relevant narcotic and opioid detection and analysis capabilities.","d":1},{"k":"p","t":"Additionally, the Government Accountability Office must conduct a study on the capabilities of the federal government to detect, identify, and otherwise respond to threats of new psychoactive substances, such as xylazine."}],"words":149},"summary":{"main_subject":{"text":"Directs the National Institute of Standards and Technology to support research and activities on detecting and analyzing xylazine, novel synthetic opioids, and other new psychoactive substances, and directs the Comptroller General to study federal capabilities to respond to such substances.","cites":[{"label":"Sec. 2","href":"https://www.congress.gov/bill/118th-congress/house-bill/1734/text/enr#H8C31561D5F8F438AA4AD2411758D29AA:~:text=2.%20Xylazine%20detection%20and%20analysis"},{"label":"Sec. 3","href":"https://www.congress.gov/bill/118th-congress/house-bill/1734/text/enr#H8F706DE045D04304BACA99FDB24275CF:~:text=3.%20Study%20on%20United%20States%20Government%20technologies"}]},"core_areas":["National Institute of Standards and Technology measurement research on xylazine, novel synthetic opioids, and other new psychoactive substances","Coordination and voluntary best practices for handling, transporting, and analyzing these substances","Comptroller General study of federal detection and identification capabilities"],"what_it_does":[{"text":"Requires the Director of the National Institute of Standards and Technology to support the Institute's intramural basic measurement science and research on analytical methods, measurement technologies, and data tools for substances containing xylazine, novel synthetic opioids, or other new psychoactive substances.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/118th-congress/house-bill/1734/text/enr#H8C31561D5F8F438AA4AD2411758D29AA:~:text=2.%20Xylazine%20detection%20and%20analysis"}},{"text":"Requires the Director to support activities that inform and expand the development of near-real time spectrometry capabilities regarding xylazine, novel synthetic opioids, and other new psychoactive substances.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/118th-congress/house-bill/1734/text/enr#H8C31561D5F8F438AA4AD2411758D29AA:~:text=2.%20Xylazine%20detection%20and%20analysis"}},{"text":"Requires the Director to convene and consult with organizations engaged in analyzing new psychoactive substances, including the Drug Enforcement Administration and the Centers for Disease Control and Prevention, to develop coordinated strategies and voluntary best practices for safe handling, transport, data-sharing, and analysis.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/118th-congress/house-bill/1734/text/enr#H8C31561D5F8F438AA4AD2411758D29AA:~:text=2.%20Xylazine%20detection%20and%20analysis"}},{"text":"Requires the Director to establish or expand partnerships or consortia with other government agencies and persons engaged in related research and development, and to encourage graduate and post-graduate research on detecting xylazine and other new psychoactive substances.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/118th-congress/house-bill/1734/text/enr#H8C31561D5F8F438AA4AD2411758D29AA:~:text=2.%20Xylazine%20detection%20and%20analysis"}},{"text":"Requires the Director to submit a report on implementation to the Senate Committee on Commerce, Science, and Transportation and the House Committee on Science, Space, and Technology not later than 1 year after enactment.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/118th-congress/house-bill/1734/text/enr#H8C31561D5F8F438AA4AD2411758D29AA:~:text=2.%20Xylazine%20detection%20and%20analysis"}},{"text":"Requires the Comptroller General to study federal capabilities to respond to new psychoactive substances such as xylazine, and to report findings to the same two committees not later than 2 years after enactment.","cite":{"label":"Sec. 3","href":"https://www.congress.gov/bill/118th-congress/house-bill/1734/text/enr#H8F706DE045D04304BACA99FDB24275CF:~:text=3.%20Study%20on%20United%20States%20Government%20technologies"}}],"unexpected":[],"version":{"type":"Enrolled Bill","date":null,"rule":"enrolled","href":"https://www.congress.gov/bill/118th-congress/house-bill/1734/text/enr"},"current":true,"model":"claude-sonnet-5-5","approved":"2026-10-02","approved_by":"checks"},"changes":{"first":{"chamber":"House","type":"Engrossed in House","date":"2023-05-11","href":"https://www.congress.gov/bill/118th-congress/house-bill/1734/text/eh"},"final":{"type":"Enrolled Bill","date":null,"href":"https://www.congress.gov/bill/118th-congress/house-bill/1734/text/enr"},"kept":0.44,"replaced":false,"removed":[],"added":[{"cite":{"label":"Sec. 3","href":"https://www.congress.gov/bill/118th-congress/house-bill/1734/text/enr#H8F706DE045D04304BACA99FDB24275CF:~:text=3.%20Study%20on%20United%20States%20Government%20technologies"},"heading":"Study on United States Government technologies and analytical methods to detect and identify new psychoactive substances","effect":"Requires the Comptroller General to study Federal Government capabilities to respond to new psychoactive substances such as xylazine, and to report findings to House and Senate committees within 2 years of enactment.","partly":null,"part":null}],"added_count":1,"approved":"2026-10-01","approved_by":"checks"},"sources":{"congress_gov":"https://www.congress.gov/bill/118th-congress/house-bill/1734","text":"https://www.congress.gov/bill/118th-congress/house-bill/1734/text"},"card":{"image":"card/item/118-hr-1734.png","v":"7f13bbe266bb","alt":"Votes on Record. H.R. 1734, 118th Congress: Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023. House: voice vote. Senate: unanimous consent. Outcome: Became law, 19 Dec 2023."}}